SCHEDULE 13D/A: Bleichroeder LP Amends Stake in Scientific Industries, Inc., Reaffirming 20.95% Beneficial Ownership
Beneficial Ownership Update
Bleichroeder LP, along with Bleichroeder Holdings LLC and Andrew Gundlach, filed Amendment No. 2 to their Schedule 13D, reaffirming beneficial ownership of 2,465,026 shares, representing 20.95% of Scientific Industries, Inc.'s Common Stock.
Summary
- This document is Amendment No. 2 to the Schedule 13D originally filed by Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach (collectively, the "Reporting Persons") concerning their beneficial ownership of Common Stock of Scientific Industries, Inc.
- The filing updates the beneficial ownership to 2,465,026 shares of Scientific Industries, Inc. Common Stock.
- This aggregate amount represents 20.95% of the Issuer's outstanding Common Stock.
- Bleichroeder LP, as an investment manager or adviser, holds sole voting and dispositive power over these shares.
- Bleichroeder Holdings LLC is the general partner of Bleichroeder LP, and Andrew Gundlach is the Chairman and CEO of Bleichroeder, owning all equity interests of Bleichroeder Holdings LLC through a trust.
- The original Schedule 13D was filed on December 15, 2023, and Amendment No. 1 was filed on November 13, 2024.
- The event requiring this filing occurred on March 19, 2025.
Sentiment
Score: 6
Explanation: The filing is a routine amendment to an existing Schedule 13D, indicating a stable, significant beneficial ownership stake by Bleichroeder LP and its affiliates in Scientific Industries, Inc. There are no explicit positive or negative operational or financial developments for the issuer mentioned, but the continued large stake by an institutional investor can be viewed as a neutral to slightly positive signal of confidence.
Positives
- A significant institutional investor, Bleichroeder LP, maintains a substantial 20.95% beneficial ownership stake in Scientific Industries, Inc., indicating continued confidence in the company.
Future Outlook
NA
Management Comments
- Andrew Gundlach, Chairman and CEO of Bleichroeder LP and Bleichroeder Holdings LLC, signed the filing on behalf of all Reporting Persons, certifying the information as true, complete, and correct to the best of his knowledge and belief.
Industry Context
This filing is a routine disclosure of beneficial ownership by an institutional investor, providing transparency on a significant equity stake in Scientific Industries, Inc. It does not contain information related to broader industry trends or competitive analysis.
Legal Proceedings
- None of the Reporting Persons (Bleichroeder LP, Bleichroeder Holdings LLC, or Andrew Gundlach) have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) in the last five years.
- None of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws, in the last five years.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 12/15/2023 | Original Schedule 13D filed by the Reporting Persons. |
| 11/13/2024 | Amendment No. 1 to the Schedule 13D filed by the Reporting Persons. |
| 03/19/2025 | Date of event which requires the filing of this statement (Amendment No. 2). |
| 03/21/2025 | Date of signing for Amendment No. 2 and the Joint Filing Agreement. |
Keywords
Scientific Industries Inc, Bleichroeder LP, Schedule 13D, beneficial ownership, common stock, institutional investor, SEC filing, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.